# Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients

> **NCT01695707** · NA · WITHDRAWN · sponsor: **University of Rochester**

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo (for pioglitazone)

## Key facts

- **NCT ID:** NCT01695707
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03
- **Primary completion:** 2014-01
- **Final completion:** 2014-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient Funding.
- **Last updated:** 2014-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01695707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01695707, "Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01695707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*